The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial

By sjmartinez • April 27, 2025

Golub LS, Manubolu VS, Aldana-Bitar J, Dahal S, Verghese D, Alalawi L, Krishnan S, Kianoush S, Benzing T, Ichikawa K, Kinninger A, Fazlalizadeh H, Pourafkari L, Ahmad K, Susarla S, Mangaoang C, Ghanem AK, Javier DA, Hamal S, Roy SK, Budoff MJ. The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial. Nutr Metab Cardiovasc Dis. 2025 Apr 5:104036. doi: 10.1016/j.numecd.2025.104036. Epub ahead of print. PMID: 40287313.

Tags: ASCVD, atherosclerotic cardiovascular disease, CAC, Cardiology/Epi, cardiovascular disease, Computed Tomography Angiography, coronary artery calcium, CTA, CVD, General Internal Medicine, GLP1 receptor agonists, Harbor UCLA, HCC, Hepatocellular carcinoma, MASH, MASLD, Metabolic dysfunction-associated Steatohepatitis, Metabolic dysfunction-associated steatotic liver disease, Publications, randomized trial, Resident, semaglutide

Efficacy and safety of bridging intravenous thrombolysis before mechanical thrombectomy: A systematic review and meta-analysis

Hashmi TM, Ahmed M, Ashraf H, Shakir M, Bhatti IA, Alareed A, Ahmed F, Hasan A, Ahmed R, Aized MT, Rafiq S, Fonarow GC, Hassan[...]

Not Premature to Quantitatively Define the Near-Field Bipolar Electrogram for Premature Ventricular Contraction Ablation

Ji S, Gupta N, Qu Z. Not Premature to Quantitatively Define the Near-Field Bipolar Electrogram for Premature Ventricular Contraction Ablation. J Arrhythm. 2025 Sep 1;41(5):e70183.[...]

Racial and Ethnic Differences in Patient Age at First Hospitalization for Heart Failure

Huang X, Hughes Z, Fonarow GC, Ahmad FS, Shah NS, Chuzi S, Kershaw KN, Greenland P, Khan SS, Petito LC. Racial and Ethnic Differences in[...]